October 3rd, 2016
By Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson
The long road to scientific discovery starts with a question.
For Dr. Paul Janssen, that question was: “What’s new?” This was the basic inquiry and profound challenge he posed to the scientists who worked in his lab every day—a reminder to always continue researching the innovations that would transform the lives of patients eagerly awaiting new healthcare solutions.
It was a simple question that led to the discovery and development of an astounding 80 new medicines before his death in 2003—medicines that made a difference for millions of patients in the areas of psychiatry, infectious disease, pain management and gastroenterology.
Dr. Paul, as most people called him, was the founder of Janssen Pharmaceutica, which became part of the Johnson & Johnson Family of Companies in 1961. He was one of the most innovative pharmaceutical researchers of our time and a true inspiration.
One of the many ways we keep his spirit alive is by celebrating the outstanding achievements of today’s scientists with the Dr. Paul Janssen Award for Biomedical Research.
Over the past decade, we’ve recognized a remarkable roster of scientists. And while their discoveries are vastly different—ranging from breakthroughs in oncology to pioneering work in viral diseases—they all have one thing in common: They embody the leadership and passion of Dr.